Learn about medications, surgery, radiation, exercise, and other therapies and strategies for symptom relief from advanced prostate cancer.

What does the new Pluvicto approval mean for prostate cancer? Here is who may qualify, how it works, benefits, side effects and treatment details.

Tumor DNA profiling could be used to identify which men with metastatic prostate cancer need aggressive treatment and those who may benefit from de-escalation.A model, trained and tested on nearly ...

About 1 in 8 men are diagnosed with prostate cancer during their lifetime. Although many survive, it can develop into metastatic disease.

This was corrected on Aug. 3, 2026. Novartis' Pluvicto was approved for use in combination with an androgen receptor pathway inhibitor. The original version incorrectly said androgen deprivation ...

Moving Beyond Imaging in metastatic castration-resistant prostate cancer: Liquid biopsy cfNA profiling of PTEN-FANCD2-POLQ as molecular signatures of response to 177Lu-PSMA-617. This is an ASCO ...

When a patient learns they have metastatic castration-sensitive prostate cancer (mCSPC), it often marks the beginning of a ...

Medically reviewed by Gagandeep Brar, MD Stage 1 and 2 prostate cancer stays in your prostate, and the five-year survival ...

Yesterday marked day one of the 2026 ASCO Genitourinary (GU) Cancers Symposium, and the updates were full of hope for people with advanced prostate cancer. CURE highlights two studies that are ...

The Prostate Cancer Foundation states that Prostate cancer is the second most commonly diagnosed type of cancer in men, following skin cancer.